Not the result I was hoping for. Best make this screw up now than during phase 3. If anything they have found an optimum product, optimum rate, to take to phase 3. I will be very interested if the fda approve commencement for the phase 3 trials. I’ve said it before, if the right combo matches products with side effects, surely I believe people with acne problems would prefer this method. So many studies coming up may improve the product also. Let’s see how keen the fda are in getting more cbd products through to understand the mechanisms of the fight against so many more problems than just acne. I wish management all the best.
Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-129
-
- There are more pages in this discussion • 522 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.055(16.9%) |
Mkt cap ! $687.8M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 38.0¢ | 33.0¢ | $7.103M | 19.63M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 134000 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 650314 | 19 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |